Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BENLYSTA for Intravenous Injection / Subcutaneous Injection Special Drug Use Investigation

NCT03370263 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03370263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03370263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BENLYSTA for Intravenous Injection / Subcutaneous Injection Special Drug Use Investigation
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
January 15, 2018
Completion date
July 31, 2025
Enrollment
1,514 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus